Unanimous FDA Panel Backs Anthrax Drug

Published November 3, 2012

Unanimous FDA Panel Backs Anthrax Drug

Filed under: drug treatment news

WASHINGTON — An FDA panel has unanimously voted in favor of approving the monoclonal antibody raxibacumab for treating inhalational anthrax, just 3 years after the agency denied approval of the same drug. The Anti-Infective Drugs Advisory Committee …
Read more on MedPage Today

Veterans divided by court system

Filed under: drug treatment news

Treatment courts are popular anyway. The justice system supports about 4,000 tribunals for drug users, drunken drivers, gamblers, homeless, mentally ill and veterans, according to the National Association of Drug Court Professionals. All are modeled …
Read more on Tribune-Review